A Review of A Priori Regression Models for Warfarin Maintenance Dose Prediction

作者: Ben Francis , Steven Lane , Munir Pirmohamed , Andrea Jorgensen

DOI: 10.1371/JOURNAL.PONE.0114896

关键词:

摘要: A number of a priori warfarin dosing algorithms, derived using linear regression methods, have been proposed. Although these algorithms may validated patients from the same centre, rarely they patient cohort recruited another centre. In order to undertake external validation, two cohorts were utilised. One formed by prospective trial and second in control arm EU-PACT trial. Of these, 641 identified as having attained stable dataset used for validation. Predicted maintenance doses six criterion fulfilling models then compared individual dose. Predictive ability was assessed with reference several statistics including R-square mean absolute error. The explained different amounts variability dose requirements validation cohorts; adjusted R-squared values ranged 24.2% 68.6%. An overview summary demonstrated that no one algorithm could be considered optimal. larger produced more consistent across algorithms. study found all performed worse when derivation cohort. Further, there little difference between contained pharmacogenetic coefficients containing just non-pharmacogenetic coefficients. inconsistency results suggests unaccounted population specific factors cause performance. Better methods take into account inter- intra-individual variability, at initiation phases treatment, are needed.

参考文章(48)
Eric G. Johnson, Benjamin D. Horne, John F. Carlquist, Jeffrey L. Anderson, Genotype-Based Dosing Algorithms for Warfarin Therapy Molecular Diagnosis & Therapy. ,vol. 15, pp. 255- 264 ,(2011) , 10.1007/BF03256417
TE Klein, RB Altman, Niclas Eriksson, BF Gage, SE Kimmel, MT Lee, NA Limdi, D Page, DM Roden, MJ Wagner, MD Caldwell, JA Johnson, YT Chen, MS Wen, Y Caraco, I Achache, S Blotnick, M Muszkat, JG Shin, HS Kim, G Suarez-Kurtz, JA Perini, E Silva-Assuncao, JL Anderson, BD Horne, JF Carlquist, RL Berg, JK Burmester, BC Goh, SC Lee, F Kamali, E Sconce, AK Daly, AH Wu, TY Langaee, H Feng, L Cavallari, K Momary, M Pirmohamed, A Jorgensen, CH Toh, P Williamson, H McLeod, JP Evans, KE Weck, C Brensinger, Y Nakamura, T Mushiroda, D Veenstra, L Meckley, MJ Rieder, AE Rettie, M Wadelius, H Melhus, CM Stein, U Schwartz, D Kurnik, E Deych, P Lenzini, C Eby, LY Chen, P Deloukas, A Motsinger-Reif, H Sagreiya, BS Srinivasan, E Lantz, T Chang, M Ritchie, LS Lu, Estimation of the warfarin dose with clinical and pharmacogenetic data The New England Journal of Medicine. ,vol. 360, pp. 753- 764 ,(2009) , 10.1056/NEJMOA0809329
Leonard Leibovici, Nachman Ash, Hillel Halkin, Aharon Lubetsky, Nitsan Maharshak, David Ezra, Idit Solomon, Gal Chechik, Applying an artificial neural network to warfarin maintenance dose prediction. Israel Medical Association Journal. ,vol. 6, pp. 732- 735 ,(2004)
Kaitlyn Shaw, Ursula Amstutz, Claudette Hildebrand, S. Rod Rassekh, Martin Hosking, Kathleen Neville, J. Steven Leeder, Michael R. Hayden, Colin J. Ross, Bruce C. Carleton, VKORC1 and CYP2C9 genotypes are predictors of warfarin-related outcomes in children Pediatric Blood & Cancer. ,vol. 61, pp. 1055- 1062 ,(2014) , 10.1002/PBC.24932
Uday P. Kulkarni, Balkrishna D. Swar, Dilip R. Karnad, Sanish Davis, Anil M. Patwardhan, Nilima A. Kshirsagar, Nithya J. Gogtay, A pilot study of the association of pharmacokinetic and pharmacodynamic parameters of warfarin with the dose in patients on long-term anticoagulation British Journal of Clinical Pharmacology. ,vol. 65, pp. 787- 790 ,(2008) , 10.1111/J.1365-2125.2008.03113.X
Farhad Kamali, Tayyaba Irfan Khan, Barry P King, Richard Frearson, Patrick Kesteven, Peter Wood, Ann K Daly, Hilary Wynne, Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin. Clinical Pharmacology & Therapeutics. ,vol. 75, pp. 204- 212 ,(2004) , 10.1016/J.CLPT.2003.10.001
John F. Carlquist, Benjamin D. Horne, Joseph B. Muhlestein, Donald L. Lappé, Bryant M. Whiting, Matthew J. Kolek, Jessica L. Clarke, Brent C. James, Jeffrey L. Anderson, Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study. Journal of Thrombosis and Thrombolysis. ,vol. 22, pp. 191- 197 ,(2006) , 10.1007/S11239-006-9030-7
Jinxing Chen, Liying Shao, Ling Gong, Fang Luo, Jin'e Wang, Yi Shi, Yu Tan, Qianlong Chen, Yu Zhang, Rutai Hui, Yibo Wang, A Pharmacogenetics-Based Warfarin Maintenance Dosing Algorithm from Northern Chinese Patients PLOS ONE. ,vol. 9, ,(2014) , 10.1371/JOURNAL.PONE.0105250
Munir Pirmohamed, Sally James, Shaun Meakin, Chris Green, Andrew K Scott, Thomas J Walley, Keith Farrar, B Kevin Park, Alasdair M Breckenridge, Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients BMJ. ,vol. 329, pp. 15- 19 ,(2004) , 10.1136/BMJ.329.7456.15
JA Perini, CJ Struchiner, E Silva-Assunção, ISC Santana, F Rangel, EB Ojopi, E Dias-Neto, G Suarez-Kurtz, Pharmacogenetics of Warfarin: Development of a Dosing Algorithm for Brazilian Patients Clinical Pharmacology & Therapeutics. ,vol. 84, pp. 722- 728 ,(2008) , 10.1038/CLPT.2008.166